Liver biopsy interpretation for causes of late liver allograft dysfunction.
about
De novo autoimmune hepatitis in liver transplant: State-of-the-art reviewRecurrence of autoimmune liver diseases after liver transplantationAutoimmune Liver Disease Post-Liver Transplantation: A Summary and Proposed Areas for Future ResearchBiliary complications after pediatric liver transplantation: Risk factors, diagnosis and managementImportance of liver biopsy findings in immunosuppression management: biopsy monitoring and working criteria for patients with operational toleranceIndications of Liver Biopsy in the Era of Noninvasive Assessment of Liver FibrosisProtocol liver biopsy is the only examination that can detect mid-term graft fibrosis after pediatric liver transplantation.ABO-compatible liver allograft antibody-mediated rejection: an update.A comprehensive review of immunosuppression used for liver transplantation.Differential expression and functions of microRNAs in liver transplantation and potential use as non-invasive biomarkers.Quantitative in situ analysis of FoxP3+ T regulatory cells on transplant tissue using laser scanning cytometry.Safety of reduced dose of mycophenolate mofetil combined with tacrolimus in living-donor liver transplantation.Autoimmune hepatitis: current challenges and future prospects.Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation.Ischemic preconditioning induces autophagy and limits necrosis in human recipients of fatty liver grafts, decreasing the incidence of rejection episodes.Recurrence of primary biliary cirrhosis and development of autoimmune hepatitis after liver transplant: A blind histologic studyLiver transplantation and autoimmune hepatitis.Q-FISH measurement of hepatocyte telomere lengths in donor liver and graft after pediatric living-donor liver transplantation: donor age affects telomere length sustainability.Epithelial to mesenchymal transition in the liver field: the double face of Everolimus in vitro.De novo autoimmune hepatitis following liver transplantation for primary biliary cirrhosis: an unusual cause of late grafts dysfunction.Production of Proinflammatory Cytokines by Monocytes in Liver-Transplanted Recipients with De Novo Autoimmune Hepatitis Is Enhanced and Induces TH1-like Regulatory T Cells.Significance of semiquantitative assessment of preformed donor-specific antibody using luminex single bead assay in living related liver transplantation.Evolving concepts in the selection of immunosuppression regimen for liver transplant recipients.Immunologic basis of graft rejection and tolerance following transplantation of liver or other solid organsChemokines in chronic liver allograft dysfunction pathogenesis and potential therapeutic targets.Current and future treatments of autoimmune hepatitis.Histopathology of de novo autoimmune hepatitis.Diagnosis, pathogenesis, and treatment of autoimmune hepatitis after liver transplantation.Post-transplant liver biopsy and the immune response: lessons for the clinician.Liver transplantation and autoimmune liver diseases.Late liver function test abnormalities post-adult liver transplantation: a review of the etiology, investigation, and management.Late graft hepatitis and fibrosis in pediatric liver allograft recipients: Current concepts and future developments.Recurrence of autoimmune liver disease and inflammatory bowel disease after pediatric liver transplantation.Impact of Antibodies That React With Liver Tissue and Donor-Specific Anti-HLA Antibodies in Pediatric Idiopathic Posttransplantation Hepatitis.Autoimmune Hepatitis in the Liver Transplant Graft.Nucleometric study of anisonucleosis, diabetes and oxidative damage in liver biopsies of orthotopic liver transplant recipients with chronic hepatitis C virus infection.Safety and performance of liver biopsies in liver transplant recipients.Longterm corticosteroid use after liver transplantation for autoimmune hepatitis is safe and associated with a lower incidence of recurrent disease.Chemotherapy-induced B-cell depletion in hepatoblastoma patients undergoing ABO-incompatible living donor liver transplantation.Case-matched comparison of ABO-incompatible and ABO-compatible living donor liver transplantation.
P2860
Q26766082-ECA237DA-655D-4D3A-A96F-E05F72CE93BAQ26774539-86624C9A-898D-4C11-8DA2-A1CEC605E747Q26786188-A1323570-5DAD-4E53-9147-69DB716E2390Q26795527-FB69EFF8-5E5E-455A-8405-7E18135CC723Q27026283-77A4453D-F7F5-4FDF-BAC4-A59FC3749214Q30368738-B1341C7C-6127-4FB2-8EB0-0F44E8DD9238Q30436974-13C7EFF0-6406-4AA8-803F-99C095045FA8Q33422561-0EC97CFF-DD62-418C-8301-29B146793CF8Q33602527-70671049-D2F7-46F6-8035-D9575BBD7C49Q33649970-9EE1EC35-3CC0-4463-9A38-6F6C3C545488Q34022412-C27C5498-81BC-4D8A-8D86-993E0BE4D919Q34339626-39DBB6AA-E55B-462B-94D2-15C63CA84EB7Q34550808-B8002D49-D801-458F-AE05-A578F46E2D29Q34646976-261C112F-0B5F-4505-9224-9BA2D38E7777Q34797602-39D4141E-5AE6-4B78-920C-01B16C090D98Q34941664-AF2C5EA4-8067-4E5B-B321-A27B9FA814D4Q35066577-978654CF-C84A-4E54-B81D-09613655C108Q35146503-B3ECD03A-C925-460B-AD2A-8647B74B35B8Q35775057-D02A1FD6-F60A-42E2-8213-A257F21E3163Q36031393-66930DFC-6371-471E-9104-060EE4EB1E02Q36921319-29B7A1B0-359A-4C03-9922-688C353DAFE6Q36925352-ECF3D876-91D8-4922-8507-73B86D9033D2Q37355472-7C091B67-5DC7-4FCE-91F0-F81B3EBB819EQ37400370-D374020D-0028-4EB1-BD31-D8203D952EB8Q37409153-6D11819B-AE63-4731-ACBB-A51FC9DD1A99Q37503380-043DAA06-D639-4E3D-B7BE-6994F7B8B512Q37989409-408CF540-FA62-492D-9129-B4F8E1AD1684Q38007886-9666553F-1650-417D-8A06-212131999ABCQ38053173-D41BDF99-3CB0-4989-B530-3F8BA5EA57B9Q38123133-2F622098-C995-402B-9620-1FF1BB083A37Q38646776-D18EFD3C-E540-43A9-8FD9-CF252784AE51Q38805764-5E2B282E-48DB-4D47-B592-FB11A5CB58BDQ38852645-224B8472-618E-4ACB-8557-3CF35BDA7BD1Q39001834-2A42D49A-1763-4F32-9C0F-76EDA666070DQ39212663-1C095DCC-EF67-4DC4-9E50-966E945650B3Q39951427-7B9F7CBE-E6A7-4055-AA69-C55A9281EC01Q40214428-0BDB8D00-2FE3-4186-9199-F02A03525DDEQ40579422-DA0AF219-D561-45E2-A802-9D84A0DBF07BQ40741639-2095BEBE-5BC8-4F3C-8C80-AC5967B8F73CQ40860739-6F9A01ED-88E1-425D-BAEC-4AE730B6B8F5
P2860
Liver biopsy interpretation for causes of late liver allograft dysfunction.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Liver biopsy interpretation for causes of late liver allograft dysfunction.
@ast
Liver biopsy interpretation for causes of late liver allograft dysfunction.
@en
type
label
Liver biopsy interpretation for causes of late liver allograft dysfunction.
@ast
Liver biopsy interpretation for causes of late liver allograft dysfunction.
@en
prefLabel
Liver biopsy interpretation for causes of late liver allograft dysfunction.
@ast
Liver biopsy interpretation for causes of late liver allograft dysfunction.
@en
P2093
P2860
P50
P356
P1433
P1476
Liver biopsy interpretation for causes of late liver allograft dysfunction.
@en
P2093
Albert Czaja
Amadeo Marcos
Andrew Clouston
Athanassios C Tsamandas
Aurelio Sonzogni
Banff Working Group
Bruno Gridelli
Charles Lassman
Chris O C Bellamy
Erin Ochoa
P2860
P304
P356
10.1002/HEP.21280
P407
P50
P577
2006-08-01T00:00:00Z